13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001596452
申报总市值
US$1.3亿
US$1.3亿
34 檔
29.6%
截至 Q1 2026 季度末，Sivik Global Healthcare LLC 的美股持仓估值约为 US$1.3亿，全数申报仓位共有 34 档。
在 Q1 2026，Sivik Global Healthcare LLC 展现出较为审慎的避险与获利了结姿态。本季共减仓 24 个仓位并完全清仓 22 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Sivik Global Healthcare LLC 的前 5 大核心持股（包含 XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026 等）合计占整体申报市值的 29.6%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 14.55% | — | -33.33% | |
| 2 | CAH | Cardinal Health Inc | 股票-医疗保健 | 3.85% | — | -26.15% | |
| 3 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | 股票-其他 | 3.81% | — | — | |
| 4 | JNJ | Johnson & Johnson | 股票-医疗保健 | 3.71% | — | — | |
| 5 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 3.65% | — | +33.33% | |
| 6 | COR | Cencora Inc | 股票-医疗保健 | 3.58% | — | -16.67% | |
| 7 | LLY | Eli Lilly & Co | 股票-医疗保健 | 3.49% | — | -28.57% | |
| 8 | WAT | Waters CORP | 股票-医疗保健 | 3.39% | — | — | |
| 9 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 3.39% | — | -27.38% | |
| 10 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.15% | — | -10.00% | |
| 11 | AZN | AstraZeneca PLC | 股票-医疗保健 | 3.00% | — | — | |
| 12 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.99% | — | -33.33% | |
| 13 | BSX | Boston Scientific CORP | 股票-医疗保健 | 2.95% | — | -11.43% | |
| 14 | DHR | Danaher CORP | 股票-医疗保健 | 2.88% | — | -13.04% | |
| 15 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 2.87% | — | -46.67% | |
| 16 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 2.65% | — | — | |
| 17 | HUM | Humana Inc | 股票-医疗保健 | 2.63% | — | +33.33% | |
| 18 | MTD | Mettler-toledo International | 股票-医疗保健 | 2.63% | — | -8.33% | |
| 19 | MCK | Mckesson CORP | 股票-医疗保健 | 2.63% | — | -55.56% | |
| 20 | A | Agilent Technologies Inc | 股票-医疗保健 | 2.60% | — | -14.29% | |
| 21 | SYK | Stryker CORP | 股票-医疗保健 | 2.50% | — | -23.08% | |
| 22 | ABBV | Abbvie Inc | 股票-医疗保健 | 2.48% | — | -25.00% | |
| 23 | UHS | Universal Health Services-b | 股票-医疗保健 | 2.38% | — | -37.50% | |
| 24 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 2.35% | — | — | |
| 25 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 2.12% | — | -16.67% | |
| 26 | BIIB | Biogen Inc | 股票-医疗保健 | 2.09% | — | -25.00% | |
| 27 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 2.05% | — | -16.67% | |
| 28 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 1.96% | — | -25.00% | |
| 29 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.95% | — | -37.50% | |
| 30 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.22% | — | -42.86% | |
| 31 | SNN | Smith & Nephew PLC -spon Adr | 股票-其他 | 1.21% | — | -60.00% | |
| 32 | ELV | Elevance Health Inc | 股票-医疗保健 | 1.11% | — | — | |
| 33 | EHC | Encompass Health CORP | 股票-医疗保健 | 1.10% | — | -70.00% | |
| 34 | CVS | Cvs Health CORP | 股票-医疗保健 | 1.09% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +6.6% | -33.33% | 减仓 |
| 2 | MRK | Merck & Co. Inc. | +2.7% | +33.33% | 加仓 |
| 3 | CAH | Cardinal Health Inc | +1.9% | -26.15% | 减仓 |
| 4 | COR | Cencora Inc | +1.8% | -16.67% | 减仓 |
| 5 | GILD | Gilead Sciences Inc | +1.8% | — | 不变 |
| 6 | VRTX | Vertex Pharmaceuticals Inc | +1.6% | -27.38% | 减仓 |
| 7 | HUM | Humana Inc | +1.5% | +33.33% | 加仓 |
| 8 | ISRG | Intuitive Surgical Inc | +1.5% | -10.00% | 减仓 |
| 9 | MTD | Mettler-toledo International | +1.4% | -8.33% | 减仓 |
| 10 | DHR | Danaher CORP | +1.4% | -13.04% | 减仓 |
| 11 | LLY | Eli Lilly & Co | +1.3% | -28.57% | 减仓 |
| 12 | A | Agilent Technologies Inc | +1.2% | -14.29% | 减仓 |
| 13 | SYK | Stryker CORP | +1.2% | -23.08% | 减仓 |
| 14 | ABBV | Abbvie Inc | +1.2% | -25.00% | 减仓 |
| 15 | BIIB | Biogen Inc | +1.1% | -25.00% | 减仓 |
| 16 | BIO | Bio-rad Laboratories-a | +1.1% | -16.67% | 减仓 |
| 17 | BSX | Boston Scientific CORP | +1% | -11.43% | 减仓 |
| 18 | TMO | Thermo Fisher Scientific Inc | +1% | -33.33% | 减仓 |
| 19 | GMED | Globus Medical Inc - A | +1% | -25.00% | 减仓 |
| 20 | UNH | Unitedhealth Group Inc | +0.9% | -16.67% | 减仓 |
| 21 | THC | Tenet Healthcare CORP | +0.7% | -46.67% | 减仓 |
| 22 | UHS | Universal Health Services-b | +0.6% | -37.50% | 减仓 |
| 23 | ABT | Abbott Laboratories | +0.5% | -37.50% | 减仓 |
| 24 | MCK | Mckesson CORP | +0.5% | -55.56% | 减仓 |
| 25 | EW | Edwards Lifesciences CORP | +0.4% | -42.86% | 减仓 |
| 26 | SNN | Smith & Nephew PLC -spon Adr | 0% | -60.00% | 减仓 |
| 27 | EHC | Encompass Health CORP | -0.4% | -70.00% | 减仓 |
| 28 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | — | EXIT | 清仓 |
| 29 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | — | EXIT | 清仓 |
| 30 | ✓ | — | EXIT | 清仓 | |
| 31 | ✓ | — | EXIT | 清仓 | |
| 32 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | — | EXIT | 清仓 |
| 33 | ✓ | — | EXIT | 清仓 | |
| 34 | ✓ | — | EXIT | 清仓 | |
| 35 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | — | EXIT | 清仓 |
| 36 | HCA | Hca Healthcare Inc | — | EXIT | 清仓 |
| 37 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | — | NEW | 新建仓 |
| 38 | JNJ | Johnson & Johnson | — | NEW | 新建仓 |
| 39 | WAT | Waters CORP | — | NEW | 新建仓 |
| 40 | MDT | Medtronic plc | — | EXIT | 清仓 |
| 41 | RGEN | Repligen CORP | — | EXIT | 清仓 |
| 42 | AZN | AstraZeneca PLC | — | NEW | 新建仓 |
| 43 | BDX | Becton Dickinson And Co | — | EXIT | 清仓 |
| 44 | NVO | Novo-nordisk A/s-spons Adr | — | EXIT | 清仓 |
| 45 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | 清仓 |
| 46 | REGN | Regeneron Pharmaceuticals | — | NEW | 新建仓 |
| 47 | SGRY | Surgery Partners Inc | — | EXIT | 清仓 |
| 48 | BRKR | Bruker CORP | — | EXIT | 清仓 |
| 49 | GEHC | GE Healthcare Technology | — | EXIT | 清仓 |
| 50 | SEM | Select Medical Holdings CORP | — | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Sivik Global Healthcare LLC 在 Q1 2026 季度的美股持仓总市值约为 US$1.3亿，共申报了 34 个公开持股仓位。
在 Q1 2026 季度，Sivik Global Healthcare LLC 按市值排列的前三大核心持股分别为：XBI (14.6%)、CAH (3.9%)、CALL- BSX 100 @ 75 EXP 04/17/2026 (3.8%)。其中最大持股仓位 XBI 占据整体投资组合约 14.6% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CALL- BSX 100 @ 75 EXP 04/17/2026
市值: US$502.0万
本季最大获利了结 / 清仓标的
PUT - SPY 100 @ 684 EXP 01/30/2026
前期市值: US$2045.8万
在 Q1 2026 季度中，Sivik Global Healthcare LLC 共进行了 55 项持仓异动，包含新建仓 7 个仓位、加仓 2 个仓位、减仓 24 个仓位以及清仓 22 个仓位。 其中最大新建仓标的为 CALL- BSX 100 @ 75 EXP 04/17/2026。 本季清仓仓位包含 PUT - SPY 100 @ 684 EXP 01/30/2026。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。